MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, DMAC has $57,047K in assets. $3,326K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1067.26%
Cash Ratio
63.14%
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Deferred offering costs
    • Others
Liabilities Breakdown
    • Paid-in capital
    • Accumulated deficit
    • Accrued liabilities
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
3,326 4,109
Marketable securities
51,992 25,929
Prepaid expenses and other assets
445 680
Amounts receivable
260 161
Deposits
200 200
Total current assets
56,223 31,079
Deferred offering costs
456 -
Operating lease right-of-use asset, net
218 239
Property, plant and equipment, gross
289 -
Less accumulated depreciation
139 -
Property and equipment, net
150 152
Deposits
0 0
Total non-current assets
824 391
Total assets
57,047 31,470
Accounts payable
1,920 1,261
Accrued liabilities
3,239 2,747
Operating lease obligation
99 96
Finance lease obligation
10 12
Total current liabilities
5,268 4,116
Operating lease obligation
150 176
Finance lease obligation
7 8
Common shares, no par value unlimited authorized 43,072,488 and 42,818,660 shares issued and outstanding, as of june 30, 2025 and december 31, 2024, respectively
-0
Total non-current liabilities
157 184
Paid-in capital
215,600 182,592
Accumulated other comprehensive income
50 -14
Accumulated deficit
-164,028 -155,408
Total shareholders equity
51,622 27,170
Total liabilities and shareholders equity
57,047 31,470
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property, plant andequipment, gross$289K Property and equipment,net$150K Operating leaseright-of-use asset, net$218K Deferred offering costs$456K Deposits$200K Amounts receivable$260K Prepaid expenses andother assets$445K Marketable securities$51,992K Cash and cashequivalents$3,326K Less accumulateddepreciation$139K Total non-currentassets$824K Total current assets$56,223K Total assets$57,047K Total liabilities andshareholders equity$57,047K Total shareholdersequity$51,622K Total non-currentliabilities$157K Total currentliabilities$5,268K Accumulated deficit-$164,028K Accumulated othercomprehensive income$50K Paid-in capital$215,600K Finance leaseobligation$7K Operating leaseobligation$150K Finance leaseobligation$10K Operating leaseobligation$99K Accrued liabilities$3,239K Accounts payable$1,920K

DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Inc. (DMAC)